Back

Phenotyping patients with precapillary pulmonary arterial hypertension PAH and a high probability of HFpEF

31 August 2025 (10:20 - 10:30)
Organised by: Logo
Congress Presentation Part of: Phenotyping and risk stratification in pulmonary arterial hypertension Diagnostic Methods ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Fabrice Bauer

University Hospitals of Paris-Sud Bicetre, Le Kremlin-Bicetre (France)

5 More presentations in this session

Presentation thumbnail
The role of age as a comorbidity in idiopathic and connective tissue disease-associated pulmonary arterial hypertension: from the Spanish Registry of Pulmonary Hypertension (REHAP Registry)
Doctor R. Bravo-Marques (Marbella, ES)
Abstract Slides Video
Presentation thumbnail
Echocardiographic assessment for responder analysis in pulmonary arterial hypertension patients treated with parenteral prostanoids
Assistant Professor S. Papa (Rome, IT)
Abstract Slides Video
Presentation thumbnail
The impact of telemedicine strategies on major cardiovascular events in post-acute coronary syndrome: a systematic review and meta-analysis
Mrs S. Del Vecchio Ziotti (Sao Paulo, BR)
Abstract Slides Video
Presentation thumbnail
Decoding WHO functional class in pulmonary hypertension: optimal integration of conventional and speckle-tracking echocardiographic parameters
Associate Professor D. Trifunovic Zamaklar (Belgrade, RS)
Abstract Slides Video
Presentation thumbnail
Infl uence Of Age In The Assessment Of Therapeutic Response In Patients With Pulmonary Arterial Hypertension
Doctor M. Salvi (Bologna, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Phenotyping and risk stratification in pulmonary arterial hypertension
Video

The Event

Event poster

ESC Congress 2025

31 August 2025 10:20 CET
You may be interested in
thumbnail
Congress Presentation
Patient phenotyping and pulmonary hypertension management: how to balance between different options
thumbnail
Congress Session
Phenotyping and risk stratification in pulmonary arterial hypertension
thumbnail
Congress Session
Pulmonary hypertension in HFpEF - Group 1 wannabe or true group 2?

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources